You are here: Home » News-CM » Companies » Results
Business Standard

Sandu Pharmaceuticals standalone net profit rises 77.78% in the December 2019 quarter

Capital Market 

Sales decline 7.12% to Rs 13.18 crore

Net profit of Sandu Pharmaceuticals rose 77.78% to Rs 0.16 crore in the quarter ended December 2019 as against Rs 0.09 crore during the previous quarter ended December 2018. Sales declined 7.12% to Rs 13.18 crore in the quarter ended December 2019 as against Rs 14.19 crore during the previous quarter ended December 2018. ParticularsQuarter EndedDec. 2019Dec. 2018% Var.Sales13.1814.19 -7 OPM %2.353.31 -PBDT0.360.35 3 PBT0.220.19 16 NP0.160.09 78

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Sat, February 15 2020. 12:00 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU